[Clinical efficacy of lower dose rituximab for chronic refractory immune thrombocytopenic purpura].

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Volumn 33, Issue 3, 2012, Pages 204-206

  Li, Yan ^a   Wang, Xiao min ^b   Mao, Min ^b   Zhang, Xiao yan ^b   Fu, Ling ^b   Ai, He mai jiang ^b   Zhang, Lian xing ^b  

^a People's Hospital of Xinjiang Uygur Autonomous Region   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; RITUXIMAB;

ADULT; ARTICLE; CLINICAL TRIAL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MIDDLE AGED; RECURRENT DISEASE; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; HUMANS; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84883493782     PISSN: 02532727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)